Back to today’s briefing

Story perspectives

Revolutionary Gene Therapy Offers Hope for Neurodegenerative Disorders

5/31/2025

49 11

Summary

Story summary

Latus Bio's groundbreaking AAV-DB-3 gene therapy tool is revolutionizing treatment for neurodegenerative disorders, including Parkinson's and Huntington's disease. In primate studies, it successfully targeted 45% of damaged neurons, paving the way for promising human applications. This innovation tackles critical hurdles in gene therapy delivery, offering hope for those affected by these debilitating conditions.

1 of 1

Story summary

Latus Bio's groundbreaking AAV-DB-3 gene therapy tool is revolutionizing treatment for neurodegenerative disorders, including Parkinson's and Huntington's disease. In primate studies, it successfully targeted 45% of damaged neurons, paving the way for promising human applications. This innovation tackles critical hurdles in gene therapy delivery, offering hope for those affected by these debilitating conditions.